Project Name ：Ramelteon 

Registration Classification：3.1

Formulations and specifications ：Tablets: 8mg 

Indications：Mainly for the treatment of insomnia, having difficulty in falling asleep, chronic insomnia with fewer adverse reactions, long-term  medication does not produce drug dependence. Suitable for the elderly, especially suitable for those with poor sleep quality, insomnia and jet lag.

Original Research Company：Japan's Takeda 

Progress：Has been reported to the State Council , the admissibility number : CXHL1400250; CXHL1400251